Organization Influence #811 32 topics · 32 mentions

Novo Nordisk

Activity (last 30 days)

Activity sparkline for the last 30 days, max 1 mentions in a single day.

Recent Topics AI-generated

  • GLP-1 Drugs Show Cardiovascular and Organ Benefits

    · 1 Sources

  • Novo Nordisk Loses Crown as Top Employer

    · 1 Sources

  • Novo Nordisk CEO Charts Path to Recovery

    · 1 Sources

  • Novo Nordisk Suffers Clinical Trial Data Breach

    · 1 Sources

  • Drugmakers Race Obesity Treatment Market

    · 1 Sources

  • Former Novo Nordisk CEO Declines New Executive Role

    · 1 Sources

  • Novo Nordisk Confirms Patient Data Breach

    · 1 Sources

  • Novo Nordisk Loses Momentum in Talent Competition

    · 1 Sources

  • Medicare Weight-Loss Drug Coverage Could Strain Doctors

    · 3 Sources

  • Hackers Claim Data Breach at Pharmaceutical Giant Novo Nordisk

    · 5 Sources

  • FulcrumSec Claims Major Breach of Novo Nordisk

    · 3 Sources

  • Healthcare Firm iRhythm Suffers Major Patient Data Breach

    · 2 Sources

  • Hackers claim to have stolen Novo Nordisk growth formula

    · 4 Sources

  • Vestas and Novo Lead Danish Stock Rally

    · 2 Sources

  • Medicare Now Covers Obesity Drugs for Seniors

    · 2 Sources

  • Wegovy Weight-Loss Pill Now Available in UK

    · 2 Sources

  • US Pursues GLP-1 Competitor Hims & Hers

    · 2 Sources

  • Novo Nordisk's Heart Drug Fails Critical Trial Phase

    · 4 Sources

  • Novo Nordisk Stock Plunges After Failed Clinical Trial

    · 2 Sources

  • Novo Nordisk accelerates obesity drug market expansion

    · 6 Sources

  • Novo Nordisk Rival Posts Better-Than-Expected Revenue

    · 2 Sources

  • Eli Lilly Gains as Novo Nordisk Signals Slowdown

    · 4 Sources

  • Fed Rate Guidance Shift Impacts Emerging Market Capital Flows

    · 2 Sources

  • Novo Nordisk Weight-Loss Pill Launches in Germany

    · 2 Sources

  • Novo Nordisk Weight Loss Pill Reshapes Market

    · 3 Sources

  • US Pharma Giant Launches Major Campaign in Danish Capital

    · 2 Sources

  • Former Celebrity Icon Faces Economic Hardship

    · 2 Sources

  • Nestlé Develops Ozempic Side-Effect Nutrition Products

    · 3 Sources

Coverage by Quality Tier

30
A
26
B
1
C
0
D

Top Sources

  • Børsen 12
  • Handelsblatt 3
  • DR 3
  • WirtschaftsWoche 3
  • CNBC 2
  • Le Monde Sciences 2
  • SecurityWeek 2
  • FT Companies 2